Lactate Dehydrogenase Levels after Aortic Valve Replacement: What Do They Tell Us?

Abstract

Introduction Lactate dehydrogenase (LDH) is a standard postoperative marker for hemolysis in the presence of paravalvular leakage (PVL) after replacement of the aortic valve (AVR). LDH is elevated in certain valves by a fluttering phenomenon. Previous studies suggested a correlation between microparticles (MPs) and LDH elevation after AVR. Thus, we analyze the postoperative relevance of LDH after AVR with transapical transcatheter aortic valves (TA-TAVs) or rapid deployment valves (RDVs).

Methods We retrospectively analyzed the data from patients who received an AVR with the RDV and TA-TAV groups between 2015 and 2018. We compared PVL and LDH levels before and after surgery, transvalvular gradients, heart block that required pacemaker implantation, and 30-day mortality.

Results In total, 138 consecutive patients were selected for the study: 79 patients in the RDV group (37 Sorin Perceval valve, 42 Edwards Intuity valve) and 59 in the TA-TAV group (Edwards Sapien valve). TA-TAV group was older (median 10 years) and had a higher incidence of PVL (odds ratio 11, 95% confidence interval [CI] 2.5–73.2, p = 0.04)). Interestingly, the TA-TAV group showed lower levels of LDH despite higher rates of PVL. Of note, the Perceval valve trended toward higher LDH values. Additionally, the RDV group showed an increased arrhythmia profile (p = 0.0041); however, the results show lower incidence in pacemaker implantation (95% CI 0.05–1.65, p = 0.635). The 30-day mortality was similar between groups.

Conclusion Our data do not support the association between hemolysis and PVL despite elevated LDH in suture-free valves. Our results suggest that LDH could be a marker of extreme heart muscle output or fluttering phenomenon and not a marker of hemolysis after sutureless AVR.

Keywords

aortic valve and root - heart valve surgery - heart valve - transapical - percutaneous (TAVI) - cardiac

Authors' Contribution

O.D. and H.R.C.B. contributed equally as the last authors of this manuscript due to their unparalleled expertise and collaborative efforts. Together, their combined expertise advanced the research and set a high standard for interdisciplinary collaboration in scientific studies.

^* These authors contributed equally.

Publikationsverlauf

Eingereicht: 12. August 2024

Angenommen: 22. Oktober 2024

Accepted Manuscript online:
01. November 2024

Artikel online veröffentlicht:
26. November 2024

• References

• 1 Osnabrugge RLJ, Mylotte D, Head SJ. et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013; 62 (11) 1002-1012
• 2 Faggiano P, Antonini-Canterin F, Baldessin F, Lorusso R, D'Aloia A, Cas LD. Epidemiology and cardiovascular risk factors of aortic stenosis. Cardiovasc Ultrasound 2006; 4: 27
• 3 Vahanian A, Beyersdorf F, Praz F. et al; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43 (07) 561-632
• 4 Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009; 373 (9667) 956-966
• 5 Kvidal P, Bergström R, Hörte LG, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000; 35 (03) 747-756
• 6 Jakobsen L, Terkelsen CJ, Søndergaard L. et al. Short- and long-term mortality and stroke risk after transcatheter aortic valve implantation. Am J Cardiol 2018; 121 (01) 78-85
• 7 Rings L, Ntinopoulos V, Dushaj S. et al. Single-center experience in sutureless aortic valve implantation using two aortic valve prostheses. J Cardiol Cardiovasc Med 2022; 7 (02) 56-60
• 8 Haeussler A, Ntinopoulos V, Rings L. et al. Thrombocytopenia after implantation of the Perceval, Intuity, and Sapien aortic valve prostheses. Thorac Cardiovasc Surg 2023; 71 (07) 550-556
• 9 Cannata A, Cantoni S, Sciortino A, Bruschi G, Russo CF. Mechanical hemolysis complicating transcatheter interventions for valvular heart disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2021; 77 (18) 2323-2334
• 10 Aljalloud A, Shoaib M, Egron S. et al. The flutter-by effect: a comprehensive study of the fluttering cusps of the Perceval heart valve prosthesis. Interact Cardiovasc Thorac Surg 2018; 27 (05) 664-670
• 11 Weber A, Liu SS, Cardone L. et al. The course of circulating small extracellular vesicles in patients undergoing surgical aortic valve replacement. BioMed Res Int 2020; 2020: 6381396
• 12 Berretta P, Di Eusanio M. Aortic valve replacement with sutureless and rapid deployment aortic valve prostheses. J Geriatr Cardiol 2016; 13 (06) 504-510
• 13 R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2022. . Accessed March 1, 2023 at: https://www.R-project.org/
• 14 Minh TH, Mazine A, Bouhout I. et al. Expanding the indication for sutureless aortic valve replacement to patients with mitral disease. J Thorac Cardiovasc Surg 2014; 148 (04) 1354-1359
• 15 Laufer G, Haverich A, Andreas M. et al. Long-term outcomes of a rapid deployment aortic valve: data up to 5 years. Eur J Cardiothorac Surg 2017; 52 (02) 281-287
• 16 Laborde F, Fischlein T, Hakim-Meibodi K. et al; Cavalier Trial Investigators. Clinical and haemodynamic outcomes in 658 patients receiving the Perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial)†. Eur J Cardiothorac Surg 2016; 49 (03) 978-986
• 17 Mack MJ, Leon MB, Thourani VH. et al; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019; 380 (18) 1695-1705
• 18 Popma JJ, Deeb GM, Yakubov SJ. et al; Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019; 380 (18) 1706-1715
• 19 Nazif TM, Dizon JM, Hahn RT. et al; PARTNER Publications Office. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc Interv 2015; 8 (1 Pt A): 60-69
• 20 Carrel T, Heinisch PP. History, development and clinical perspectives of sutureless and rapid deployment surgical aortic valve replacement. Ann Cardiothorac Surg 2020; 9 (05) 375-385
• 21 Shrestha M, Fischlein T, Meuris B. et al. European multicentre experience with the sutureless Perceval valve: clinical and haemodynamic outcomes up to 5 years in over 700 patients. Eur J Cardiothorac Surg 2016; 49 (01) 234-241
• 22 Liakopoulos OJ, Gerfer S, Rahmanian P. et al. Rapid deployment aortic valve replacement with the Perceval S and Intuity Elite. Thorac Cardiovasc Surg 2021; 69 (05) 412-419
• 23 Hermiller Jr JB, Yakubov SJ, Reardon MJ. et al; CoreValve United States Clinical Investigators. Predicting early and late mortality after transcatheter aortic valve replacement. J Am Coll Cardiol 2016; 68 (04) 343-352
• 24 Leon MB, Smith CR, Mack M. et al; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363 (17) 1597-1607
• 25 Haensig M, Lehmkuhl L, Rastan AJ. et al. Aortic valve calcium scoring is a predictor of significant paravalvular aortic insufficiency in transapical-aortic valve implantation. Eur J Cardiothorac Surg 2012; 41 (06) 1234-1240 , discussion 1240–1241
• 26 Di Eusanio M, Phan K. Sutureless aortic valve replacement. Ann Cardiothorac Surg 2015; 4 (02) 123-130
• 27 Unbehaun A, Pasic M, Dreysse S. et al. Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients. J Am Coll Cardiol 2012; 59 (03) 211-221
• 28 Szunerits S, Mishyn V, Grabowska I, Boukherroub R. Electrochemical cardiovascular platforms: Current state of the art and beyond. Biosens Bioelectron 2019; 131: 287-298
• 29 Zhu W, Ma Y, Guo W. et al. Serum level of lactate dehydrogenase is associated with cardiovascular disease risk as determined by the Framingham Risk Score and arterial stiffness in a health-examined population in China. Int J Gen Med 2022; 15: 11-17
• 30 Leverett LB, Hellums JD, Alfrey CP, Lynch EC. Red blood cell damage by shear stress. Biophys J 1972; 12 (03) 257-273
• 31 Sutera SP. Flow-induced trauma to blood cells. Circ Res 1977; 41 (01) 2-8
• 32 Lacasse D, Garon A, Pelletier D. Mechanical hemolysis in blood flow: user-independent predictions with the solution of a partial differential equation. Comput Methods Biomech Biomed Engin 2007; 10 (01) 1-12
• 33 Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21 (03) 157-171
• 34 Ibrahim A, Marbán E. Exosomes: fundamental biology and roles in cardiovascular physiology. Annu Rev Physiol 2016; 78: 67-83
• 35 Ludwig A-K, Giebel B. Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol 2012; 44 (01) 11-15